Table 3. Cytotoxic activity of various compounds against various cancerous cell lines.
| Compounds | Concentration (μg/ml) |
Cell lines |
|||
|---|---|---|---|---|---|
| Liver | Neuroblastoma |
Colon |
|||
| HEP-2 | IMR-32 | HCT-15 | 502713 | ||
| Growth inhibition (%) ± SD | |||||
| SF (Wtmn) | 10 | 49 ± 0.71 | − | 74 ± 1.41 | 76 ± 1.41 |
| SF (Wtmn) | 30 | 52 ± 1.41 | − | 91 ± 2.12 | 89 ± 2.82 |
| Actinomycin D | 10 | 66 ± 2.83 | 68 ± 0.71 | 70 ± 0.71 | 69 ± 0.71 |
| Actinomycin D | 30 | 82 ± 1.41 | 87 ± 0.71 | 72 ± 1.76 | 98 ± 2.12 |
| Mito-C | 3.34 | 82 ± 0.71 | 87 ± 0.71 | − | 86 ± 2.47 |
| Adriamycin | 0.54 | 79 ± 0.71 | 89 ± 1.41 | − | 22 ± 2.12 |
| 5-Fu | 6.12 | − | − | 27 ± 1.41 | 15 ± 2.12 |
Note: (−): No activity